Mochida Pharmaceutical Co.,Ltd. FY2027 Q1 Earnings Report

Quick View

Executive Summary

The current Q1 results can be characterized as clearly demonstrating a trend of higher revenue and earnings, driven by double-digit revenue growth alongside progress in SG&A efficiency. Revenue was ¥317.2B (+19.1% year on year), while operating income was ¥35.6B (+38.5%), with earnings growth exceeding revenue growth. Ordinary income was ¥41.9B (+50.5%), and net income attributable to owners of the parent was ¥31.8B (+67.8%), with the growth rate expanding at each successive earnings level. The primary drivers of earnings growth were operating leverage resulting from the decline in the SG&A ratio (35.1%, compared with 41.5% in the previous year), as well as contributions from nonrecurring factors such as equity-method investment income and gains on sales of investment securities of ¥6.9B.

Factors Affecting Business Performance

【Revenue】Although the only reported segment is the Pharmaceutical-Related Business and detailed disclosure by region and product is not provided, revenue increased by +19.1% to ¥317.2B from ¥266.3B in the previous year. The growth rate was below those of operating income (+38.5%) and ordinary income (+50.5%), highlighting that earnings expanded more rapidly than revenue.

【Profit and Loss】The gross profit margin declined by 4.9pt to 46.3% from 51.2% in the previous year, suggesting an increase in costs or a change in the product mix. Meanwhile, SG&A expenses increased only +0.6%, and the SG&A-to-revenue ratio improved by 6.4pt to 35.1% from 41.5% in the previous year. Consequently, the operating margin rose by 1.6pt to 11.2% from 9.7%. At the ordinary income level, non-operating income, including equity-method investment income of ¥3.8B and dividends received of ¥2.8B, contributed to growth, lifting the ordinary income margin to 13.2% from 10.5% in the previous year. Although a gain on sales of investment securities of ¥6.9B was recorded as extraordinary income, the effective tax rate increased to 34.7% from 31.9% in the previous year; nevertheless, net income increased substantially to ¥31.8B (+67.8%). In conclusion, the current results represent higher revenue and higher earnings.

Key Financial Indicators

【Profitability】The operating margin of 11.2% (9.7% in the previous year), ordinary income margin of 13.2% (10.5% in the previous year), and net income margin of 10.0% (7.1% in the previous year) all improved, while the gross profit margin declined by 4.9pt to 46.3% from 51.2% in the previous year. Accordingly, the improvement in profitability this period was primarily attributable to SG&A efficiency. 【Cash Quality】Quarterly turnover days relative to revenue and costs were approximately 107 days for trade receivables (125 days in the previous year), approximately 103 days for inventories (141 days in the previous year), and approximately 55 days for trade payables (68 days in the previous year). The resulting cash conversion cycle shortened by approximately 42 days to approximately 155 days from 197 days in the previous year, indicating an improving trend in working capital efficiency. 【Investment Efficiency】ROE based on net income attributable to owners of the parent was 2.3% (quarterly actual, before annualization), comprising a net income margin of 10.0%, total asset turnover of 0.17x (quarterly), and financial leverage of 1.29x. 【Financial Soundness】The equity ratio remained high at 77.3% (76.8% in the previous year), while ample liquidity was secured, with a current ratio of 394% and a quick ratio of 323%. Against long-term borrowings of ¥100B, the company held cash and deposits of ¥254.2B and investment securities of ¥372.9B. Interest expense was only ¥0.4B, indicating an extremely light interest-payment burden.

Cash Flow Analysis

As an individual cash flow statement is not disclosed, cash movements are analyzed based on changes in the balance sheet. Cash and deposits amounted to ¥254.2B, down ¥26.5B (-9.4%) from ¥280.6B at the end of the previous fiscal year. Retained earnings increased by only ¥17.6B; based on the difference from net income of ¥31.8B, approximately ¥14.2B is estimated to have been paid as dividends. Treasury stock increased to ¥35.9B from ¥32.7B at the end of the previous fiscal year, suggesting that approximately ¥3.2B was used for share repurchases. On the asset side, long-term prepaid expenses increased substantially from ¥50.7B to ¥183.4B, while other current assets declined significantly from ¥153.6B to ¥44.8B, possibly indicating a shift in funds from short-term assets to long-term assets. Total assets were ¥1814.2B, approximately unchanged from the previous fiscal year. Overall, the company appears to have allocated funds in a balanced manner between investment and shareholder returns while maintaining liquidity on hand.

Quality of Earnings

In terms of earnings quality, recurring earnings improvement was primarily driven by SG&A efficiency, suggesting relatively high sustainability. However, ordinary income was boosted by ¥7.1B in non-operating income, comprising equity-method investment income of ¥3.8B and dividends received of ¥2.8B, indicating a relatively large contribution from factors outside the core business. A gain on sales of investment securities of ¥6.9B was recorded as extraordinary income, representing a one-time factor. The effective tax rate increased to 34.7% from 31.9% in the previous year, and the higher tax burden acted to restrain the growth rate of net income (+67.8%) relative to the growth rate of profit before tax (+74.9%). Comprehensive income was only ¥17.0B, resulting in a ¥14.8B gap from net income of ¥31.8B. This was primarily due to a negative ¥14.5B change in the valuation difference on other securities, and comprehensive income also declined by -9.2% from ¥18.8B in the same period of the previous year. Despite substantial growth in net income, comprehensive income was below the previous year. The fact that changes in the market value of held securities reduced the ultimate increase in equity is an important consideration when evaluating earnings quality.

Earnings Forecasts and Guidance

The Q1 progress rates against the full-year company plan were 25.2% for revenue, 33.9% for operating income, 33.5% for ordinary income, and 31.8% for net income, with profit items progressing above the simple 25% benchmark. The full-year plan calls for revenue of ¥1260.0B (+7.7% from the previous fiscal year), operating income of ¥105.0B (+3.5%), and ordinary income of ¥125.0B (+11.6%). The growth rates in the current Q1—revenue +19.1%, operating income +38.5%, and ordinary income +50.5%—are therefore running ahead of the assumptions underlying the full-year plan. No revisions to the earnings forecast or dividend forecast were disclosed this time. The above-plan progress rates include contributions from nonrecurring factors such as equity-method investment income and gains on sales of investment securities. Toward the full year, the reversal of these one-time factors and trends in the gross profit margin will be key considerations in assessing the sustainability of progress.

Shareholder Returns

Under the company’s plan, the annual dividend forecast is ¥85 per share, and no revision to the dividend forecast had been made as of the current quarter. The payout ratio against the company’s planned EPS of ¥282.86 is approximately 30.0% (¥85/¥282.86), which remains at a reasonable level. Changes in the balance sheet during the current Q1 indicate that treasury stock increased from ¥32.7B to ¥35.9B, suggesting that approximately ¥3.2B was used for share repurchases. From the perspective of total shareholder returns, given the ample funds on hand—cash and deposits of ¥254.2B and investment securities of ¥372.9B—and the conservative financial structure, with long-term borrowings limited to ¥100B, the company appears to retain sufficient resources for shareholder returns.

Risk Factors

1. Decline in Gross Profit Margin: The gross profit margin declined by 4.9pt to 46.3% from 51.2% in the previous year. This appears to have been affected by higher costs or changes in the product mix. Although the decline was offset this period by SG&A efficiency (SG&A ratio -6.4pt), continued deterioration in the same direction could reduce the scope for further improvement in the operating margin.

2. Nonrecurring Earnings and Higher Tax Burden: The increase in ordinary income and net income includes nonrecurring factors such as equity-method investment income of ¥3.8B and gains on sales of investment securities of ¥6.9B. The effective tax rate also increased to 34.7% from 31.9% in the previous year. If these factors dissipate, the earnings growth rate may contract.

3. Risk of Valuation Fluctuations in Securities: The change in the valuation difference on other securities was negative ¥14.5B, and comprehensive income was limited to ¥17.0B, down -9.2% year on year. The company holds investment securities of ¥372.9B, creating a structure in which market fluctuations affect net assets and comprehensive income.

Industry Benchmarks (Reference; Compiled by the Company)

Profitability and Returns

The operating margin is below the industry median, whereas the net income margin exceeds the median, indicating differing positioning across the stages of the earnings structure.

Growth and Capital Efficiency

The revenue growth rate is substantially above the industry median, placing the company at a level within the upper group.

Source: Compiled by the Company

Key Points in the Financial Results

1. The SG&A ratio declined by 6.4pt to 35.1% from 41.5% in the previous year, lifting the operating margin. The fact that SG&A efficiency more than offset the 4.9pt decline in the gross profit margin is noteworthy as a change in the cost structure.

2. Turnover days for trade receivables and inventories (on a quarterly basis) both shortened from the previous year, and the cash conversion cycle improved from approximately 197 days to approximately 155 days. The improvement in working capital efficiency is positive from a cash efficiency perspective.

3. Net income increased substantially by +67.8% year on year, but comprehensive income was limited to ¥17.0B, down -9.2% year on year. Due to fluctuations in the valuation difference on securities, the ultimate increase in equity did not expand to the same extent as net income. The divergence between earnings growth in the income statement and the increase in equity on a comprehensive basis is an important point when evaluating the quality of the results.

Theoretical Share Price (Reference Value)

This is a reference range mechanically calculated solely from publicly disclosed data using a residual income model (Ohlson-type model with an explicit 5-year fade). It is not a forecast of the market share price or a recommendation to take any specific investment action.

Sensitivity: ¥3,650–¥3,863 at cost of equity ±1%; ¥3,747–¥3,759 at ω±0.1.

Notes:

• Because forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets at the end of the quarter are used (there is a timing difference from the full-year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model / Interest Rate Reference Month: 2026-06 / This value does not forecast or guarantee the future share price)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, and after consulting a professional adviser as necessary.

---End of Report---